EXOZYMES INC. — Director's Dealing 2025

Jul 2, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXOZYMES INC. (EXOZ)
CIK: 0002010788
Period of Report: 2025-07-02

Reporting Person: Heltzen Michael (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-07-02	Common Stock	P	1040	$10.22	Acquired	10628.80	Direct